MarketCap
Facebook
X
TelegramAnnual report 2025
added 01-12-2026
Anixa Biosciences P/E Ratio 2011-2026 | ANIX
Annual P/E Ratio Anixa Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00947 | -0.00564 | -0.0154 | -0.0101 | -4.64 | -5.81 | -6.51 | -4.94 | -6.09 | -10.9 | -19.6 | -4.23 | -4.5 | -9.39 | -3.23 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.00564 | -19.6 | -5.33 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-37.1 | $ 23.38 | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 34.06 | 0.86 % | $ 367 M |  China |
 |
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
-0.0317 | $ 1.3 | - | $ 1.65 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
39 | $ 218.89 | - | $ 160 B | USA |
 |
Co-Diagnostics
CODX
|
-0.988 | - | - | $ 79.8 M | USA |
 |
Castle Biosciences
CSTL
|
38.9 | $ 39.39 | - | $ 1.09 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-10.8 | $ 102.34 | - | $ 19 B | USA |
 |
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
90.1 | $ 73.04 | -1.3 % | $ 28.2 B | USA |
 |
Guardant Health
GH
|
-13.4 | $ 114.04 | - | $ 14 B | USA |
 |
CareDx, Inc
CDNA
|
-2.74 | $ 20.55 | -1.2 % | $ 1.1 B | USA |
 |
Celcuity
CELC
|
-3.57 | $ 109.42 | - | $ 4.32 B | USA |
 |
DarioHealth Corp.
DRIO
|
-0.73 | $ 10.02 | - | $ 284 M | Israel |
 |
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
-10.9 | $ 26.2 | - | $ 792 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | USA |
 |
IDEXX Laboratories
IDXX
|
42.4 | $ 670.46 | - | $ 55.3 B | USA |
 |
Illumina
ILMN
|
-13.4 | $ 144.81 | -3.26 % | $ 23 B | USA |
 |
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
26 | $ 230.15 | - | $ 41.7 B | USA |
 |
Medpace Holdings
MEDP
|
25.2 | $ 582.48 | - | $ 18 B | USA |
 |
Charles River Laboratories International
CRL
|
385 | $ 210.48 | - | $ 10.8 B | USA |
 |
NeoGenomics
NEO
|
-19.4 | $ 12.06 | - | $ 1.53 B | USA |
 |
National Research Corporation
NRC
|
32.6 | $ 20.34 | - | $ 499 M | USA |
 |
Lantheus Holdings
LNTH
|
20.7 | $ 66.92 | - | $ 4.63 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 187.03 | - | $ 20.8 B | USA |
|
Biodesix
BDSX
|
-2.14 | $ 10.17 | - | $ 1.32 B | USA |
 |
Precipio
PRPO
|
-1.49 | $ 24.54 | - | $ 31.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
28.3 | $ 271.52 | - | $ 22.8 B | USA |
 |
ICON Public Limited Company
ICLR
|
21 | $ 180.25 | - | $ 14.9 B |  Irlanda |
 |
Agilent Technologies
A
|
34.7 | $ 133.85 | - | $ 40.7 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.27 | $ 28.7 | - | $ 20 B | Niderland |
 |
Biomerica
BMRA
|
-1.45 | $ 2.38 | - | $ 5.47 M | USA |
 |
OpGen
OPGN
|
0.761 | - | -16.95 % | $ 1.54 M | USA |
 |
Bioventus
BVS
|
-2.25 | $ 7.93 | - | $ 497 M | USA |